# Alamar Biosciences (ALMR) — News

ALMR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/almr/news

## Recent headlines

- [Alamar Biosciences names former Grail CEO Bob Ragusa to board of directors and expands leadership team](https://www.ainvest.com/news/alamar-biosciences-names-grail-ceo-bob-ragusa-board-directors-expands-leadership-team-2610) — AInvest Wire, Oct 5, 2026
- [Lancet Neurology study using Alamar Biosciences' technology reveals divergent biological responses to Alzheimer's treatment](https://www.ainvest.com/news/lancet-neurology-study-alamar-biosciences-technology-reveals-divergent-biological-responses-alzheimer-treatment-2609) — AInvest Wire, Sep 24, 2026
  A recent study published in The Lancet Neurology has highlighted divergent biological responses to Alzheimer's disease treatments, leveraging Alamar Biosciences' advanced proteomic technologies. The research, conducted using the NULISAseq CNS Disease Panel 120, analyzed plasma samples from 193…
- [Alamar Biosciences outlook FY revenue $116 mln-$120 mln](https://www.ainvest.com/news/alamar-biosciences-outlook-fy-revenue-116-mln-120-mln-2608) — AInvest Wire, Aug 10, 2026
- [Alamar Biosciences Q2 revenue $29.4 million](https://www.ainvest.com/news/alamar-biosciences-q2-revenue-29-4-million-2608) — AInvest Wire, Aug 10, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).